Literature DB >> 21376738

Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy.

Christopher Allen1, Thomas B Borak, Hirohiko Tsujii, Jac A Nickoloff.   

Abstract

Ionizing radiation causes many types of DNA damage, including base damage and single- and double-strand breaks. Photons, including X-rays and γ-rays, are the most widely used type of ionizing radiation in radiobiology experiments, and in radiation cancer therapy. Charged particles, including protons and carbon ions, are seeing increased use as an alternative therapeutic modality. Although the facilities needed to produce high energy charged particle beams are more costly than photon facilities, particle therapy has shown improved cancer survival rates, reflecting more highly focused dose distributions and more severe DNA damage to tumor cells. Despite early successes of charged particle radiotherapy, there is room for further improvement, and much remains to be learned about normal and cancer cell responses to charged particle radiation. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376738      PMCID: PMC3101308          DOI: 10.1016/j.mrfmmm.2011.02.012

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  66 in total

Review 1.  Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS).

Authors:  Tohru Okada; Tadashi Kamada; Hiroshi Tsuji; Jun-etsu Mizoe; Masayuki Baba; Shingo Kato; Shigeru Yamada; Shinji Sugahara; Shigeo Yasuda; Naoyoshi Yamamoto; Reiko Imai; Azusa Hasegawa; Hiroshi Imada; Hiroki Kiyohara; Kenichi Jingu; Makoto Shinoto; Hirohiko Tsujii
Journal:  J Radiat Res       Date:  2010-05-28       Impact factor: 2.724

2.  Proton beam radiation therapy for skull base adenoid cystic carcinoma.

Authors:  Pascal Pommier; Nobert J Liebsch; Daniel G Deschler; Derrick T Lin; James F McIntyre; Fred G Barker; Judy A Adams; Vrishali V Lopes; Mark Varvares; Jay S Loeffler; Annie W Chan
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-11

Review 3.  Ion beam radiobiology and cancer: time to update ourselves.

Authors:  Emmanouil Fokas; Gerhard Kraft; Hanxiang An; Rita Engenhart-Cabillic
Journal:  Biochim Biophys Acta       Date:  2009-08-12

4.  Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma.

Authors:  Robert Krempien; Falk Roeder; Susanne Oertel; Jürgen Weitz; Frank W Hensley; Carmen Timke; Angela Funk; Katja Lindel; Wolfgang Harms; Markus W Buchler; Jürgen Debus; Martina Treiber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-06       Impact factor: 7.038

Review 5.  Targeting base excision repair as a sensitization strategy in radiotherapy.

Authors:  Conchita Vens; Adrian C Begg
Journal:  Semin Radiat Oncol       Date:  2010-10       Impact factor: 5.934

6.  The use of chromosomal aberrations in human lymphocytes for biological dosimetry.

Authors:  A A Edwards
Journal:  Radiat Res       Date:  1997-11       Impact factor: 2.841

7.  Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon (56)Fe ions.

Authors:  Michael M Weil; Joel S Bedford; Helle Bielefeldt-Ohmann; F Andrew Ray; Paula C Genik; Eugene J Ehrhart; Christina M Fallgren; Fitsum Hailu; Christine L R Battaglia; Brad Charles; Matthew A Callan; Robert L Ullrich
Journal:  Radiat Res       Date:  2009-08       Impact factor: 2.841

Review 8.  Current management for late normal tissue injury: radiation-induced fibrosis and necrosis.

Authors:  Sylvie Delanian; Jean-Louis Lefaix
Journal:  Semin Radiat Oncol       Date:  2007-04       Impact factor: 5.934

Review 9.  Radioprotection.

Authors:  Joel S Greenberger
Journal:  In Vivo       Date:  2009 Mar-Apr       Impact factor: 2.155

10.  Significance and implementation of RBE variations in proton beam therapy.

Authors:  H Paganetti
Journal:  Technol Cancer Res Treat       Date:  2003-10
View more
  35 in total

1.  Improving cancer therapy by combining cell biological, physical, and molecular targeting strategies.

Authors:  Jac A Nickoloff
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

2.  TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.

Authors:  Younghyun Lee; Shigeaki Sunada; Hirokazu Hirakawa; Akira Fujimori; Jac A Nickoloff; Ryuichi Okayasu
Journal:  Mol Cancer Ther       Date:  2016-11-09       Impact factor: 6.261

Review 3.  The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models.

Authors:  Takashi Shimokawa; Liqiu Ma; Ken Ando; Katsutoshi Sato; Takashi Imai
Journal:  Int J Part Ther       Date:  2016-08-29

Review 4.  Strategies to Enhance Radiosensitivity to Heavy Ion Radiation Therapy.

Authors:  Younghyun Lee; Ryuichi Okayasu
Journal:  Int J Part Ther       Date:  2018-09-21

5.  The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.

Authors:  Younghyun Lee; Huizi Keiko Li; Aya Masaoka; Shigeaki Sunada; Hirokazu Hirakawa; Akira Fujimori; Jac A Nickoloff; Ryuichi Okayasu
Journal:  Radiother Oncol       Date:  2016-09-22       Impact factor: 6.280

6.  Photon, light ion, and heavy ion cancer radiotherapy: paths from physics and biology to clinical practice.

Authors:  Jac A Nickoloff
Journal:  Ann Transl Med       Date:  2015-12

Review 7.  Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy.

Authors:  Adeola Y Makinde; Molykutty John-Aryankalayil; Sanjeewani T Palayoor; David Cerna; C Norman Coleman
Journal:  Mol Cancer Res       Date:  2012-11-21       Impact factor: 5.852

Review 8.  Particle therapy for cancers: a new weapon in radiation therapy.

Authors:  Guo-Liang Jiang
Journal:  Front Med       Date:  2012-05-09       Impact factor: 4.592

9.  Simulation of dose distribution and secondary particle production in proton therapy of brain tumor.

Authors:  Zahra Hashemi; Mansoureh Tatari; Haladhara Naik
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-03

10.  Application of Carbon Ion and Its Sensitizing Agent in Cancer Therapy: A Systematic Review.

Authors:  Xiaolin Wang; Xiaojun Chen; Guangfei Li; Xiao Han; Tianxin Gao; Weifeng Liu; Xiaoying Tang
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.